Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
19 September, 2018 14:46 IST
Lupin launches generic Safyral tablets in United States
Source: IRIS | 14 Mar, 2018, 09.39AM
Comments  |  Post Comment

Pharma major Lupin announced the launch of its Tydemy Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin's Tydemy (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg & Levomefolate Calcium, 0.451mg) are the generic equivalents of Bayer HealthCare Pharmaceuticals Inc.'s Safyral tablets. It is indicated for use by women to prevent pregnancy and to raise folate levels in women who choose to use an oral contraceptive for contraception.

Drospirenone, EE, Levomefolate Calcium, 3mg/0.03mg/0.451mg & Levomefolate Calcium, 0.451mg tablets had annual sales of approximately USD 22 million in the US (IQVIA January 2018).

Shares of the company gained Rs 4.1, or 0.53%, to trade at  Rs 784.95.  The total volume of shares traded  was  5,849 at the BSE (9.29 a.m., Wednesday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Company Update
Glenmark Pharma inducted into DJSI Emerging Market 2018 - 19-Sep-2018 12:09
TVS Motor Co strengthens presence in Mexico - 19-Sep-2018 11:56
Himachal Futuristic Communications bags order worth Rs 6.11 bn - 19-Sep-2018 11:52
Tata Steel completes acquisition of Creative Port Development - 19-Sep-2018 11:48
SABIC acquires 24.99% stake in Clariant globally - 19-Sep-2018 11:45
Tata Power launches its VoiceBOT TINA - 19-Sep-2018 11:42
Sun Pharma gets European Commission nod for ILUMETRI - 18-Sep-2018 17:02
Indian Hume Pipe receives LoA for order worth Rs 2.21 bn - 18-Sep-2018 16:58
Tata iQ selects TCS Jile to Drive Agile Transformation - 18-Sep-2018 16:48
Strides Pharma Science completes inspection for product pre-approval - 18-Sep-2018 16:39
Government to merge Dena Bank, Vijaya Bank, Bank of Baroda - 18-Sep-2018 15:33
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer